CTNNB1 Neurodevelopmental Syndrome - Natural History Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Medical Centre Ljubljana

About this trial

The aim of the Dragonfly study is to characterise and monitor the neurodevelopment of children and adults diagnosed with CTNNB1 syndrome through an international collaborative effort. Gaining comprehensive understanding of the mental, physical and social development of people with CTNNB1 neurodevelopmental syndrome and how their symptoms and abilities change over time will help improve and standardize care for these patients, as well as facilitate future research and clinical trials design.

Eligibility criteria

Qualifiers

Clinically and genetically confirmed diagnosis of CTNNB1 syndrome.

Age 0-99 years.

Written informed consent/online consent to participate in study from a primary carer (parent or legal guardian).

Disqualifiers

Child/adult with CTNNB1 syndrome participating in a clinical trial of a potential treatment for the syndrome.

Trial design

Treatments tested in this trial

  • A General Medical and Neurological Assessment
  • World Health Organisation (WHO) Motor Milestones
  • Burke-Fahn-Marsden Dystonia Rating Scale
  • Spastic Paraplegia Rating Scale
  • 5. CTNNB1-Related Neurodevelopmental Disorder (NEDSDV) Cardiac Health Questionnaire
  • 10m Walk-Run Test
  • The Nine Hole Peg Test
  • The Gross Motor Function Classification System
  • Bayley Scales of Infant and Toddler Development-4: Fine Motor, Gross Motor, Language, and Cognitive Scales
  • Wechsler Non-Verbal Scale of Ability
  • The Vineland Adaptive Behaviour Scales - 3
  • Aberrant Behaviour Checklist -Community
  • The Modified Checklist for Autism in Toddlers
  • The Autism Spectrum Quotient Questionnaire -Children's Version
  • The Autism-Spectrum Quotient (AQ)-Adolescent Version
  • Continuous Movement Monitoring (Actimyo/Syde)
  • Sleep Disturbance Scale for Children
  • Seizure Diary
  • 30min EEG Recording
  • PedsQL Family Impact Module
  • PedsQL Core Module
  • Blood Sample Collection
  • Optical Coherence Tomography
  • Brain MRI

Treatment groups

250 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Medical Centre Ljubljana

Lead sponsor

The University of New South Wales

Collaborator

University of Ljubljana School of Medicine, Slovenia

Collaborator

CTNNB1 Foundation

Collaborator